• Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryElshorbagy, Amany; Vallejo-Vaz, Antonio J.; Barkas, Fotios; Lyons, Alexander R. M.; Stevens, Christophe A. T.; Dharmayat, Kanika I.; Catapano, Alberico L.; Freiberger, Tomas; Hovingh, G. Kees; Viigimaa, MargusEuropean Heart Journal2025 / 14 p : ill https://doi.org/10.1093/eurheartj/ehae791 https://www.scopus.com/sourceid/23183 https://www.scopus.com/pages/publications/105002060375?origin=resultslist https://jcr.clarivate.com/jcr-jp/journal-profile?journal=EUR%20HEART%20J&year=2024 https://www.webofscience.com/wos/woscc/full-record/WOS:001439564700001
• Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 1 : Pathophysiology and key clinical studiesZlatkina, Vira; Nesen, Andriy; Demikhova, NadiiaUkrainian Journal of Nephrology and Dialysis2025 / p. 88-97 https://doi.org/10.31450/ukrjnd.4(88).2025.10 https://ukrjnd.com.ua/index.php/journal/article/view/998